13F Holdings
中文EN

POM POMDOCTOR Ltd Annual reports only

Retail-Miscellaneous Retail · Nasdaq · SEC CIK 1877971 · Fiscal year ends 12/31

Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY—
TTM net income YoY—
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin13.1%
Operating margin-29.7%
Net margin-32.7%
FCF margin-37.4%
EBITDA margin-29.6%

Returns

ROE—
ROA-121.7%
ROIC (approx.)—
Asset turnover3.72x

Leverage & solvency

Liabilities / assets547.5%
Debt / equity—
Current ratio0.48x
Interest coverage-30.11x

Cash quality & payout

Operating cash flow / net income1.13x
Accruals ratio16.3%
Payout ratio—
Capex / revenue0.3%

Factor history charts and full statement history on Pro 🔒

Financial statements

Annual Quarterly (none) Export CSV 🔒
Line item FY2025*2025-12-31 · USDFY2024*2024-12-31 · CNYFY2023*2023-12-31 · CNY
Income statement
Revenue$57.19M342.56M304.85M
Cost of revenue$49.71M294.86M266.13M
Gross profit$7.48M47.69M38.72M
R&D expense$1.84M3.00M3.37M
SG&A expense$8.54M11.88M12.31M
Operating income-$16.96M-25.79M-22.25M
Interest expense$563,4643.63M3.00M
Pretax income-$18.72M-37.37M-36.95M
Income tax$54——
Net income-$18.72M-37.39M-36.95M
EBITDA-$16.94M-25.66M-22.14M
EPS (basic)-3.14-22.72-23.04
EPS (diluted)-3.14-22.72-23.04
Weighted avg. shares (diluted)9.68M6.31M6.31M
Banking
Deposits$1.35M7.60M6.68M
Balance sheet
Cash & equivalents$1.37M7.65M6.72M
Receivables$2.64M8.37M—
Inventory$1.18M9.17M—
Current assets$15.01M37.50M—
PP&E, net$178,257461,362—
Total assets$15.38M46.23M—
Current liabilities$31.20M179.15M—
Short-term debt$7.58M34.96M—
Long-term debt$11.70M——
Total debt$19.28M——
Total liabilities$84.21M545.91M—
Shareholders' equity-$64.92M-2.26B-2.12B
Net debt$17.91M——
Cash flow statement
Operating cash flow-$21.23M-16.13M-45.80M
Capital expenditure$144,10737,773111,891
Free cash flow-$21.38M-16.17M-45.91M
Investing cash flow-$229,906-33,373-111,891
Financing cash flow$22.01M17.02M50.07M
Depreciation & amortization$21,351134,510112,092
Stock-based compensation$2.35M——

· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.

· This company uses different currencies across periods or line items (e.g. USD convenience translations in annual reports). Each column header shows its currency and cells in a different currency are marked; do not compare figures across currencies. Charts use only periods in the latest period's currency.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.